What Researchers Did
Researchers conducted a literature review to assess the efficacy of hyperbaric oxygen therapy (HBO) in treating refractory anal fistulas in Crohn's disease.
What They Found
Among 22 patients from four selected publications, 15 (68.18%) achieved remission with hyperbaric oxygen therapy, a rate comparable to infliximab's 66%. Adverse events were observed in 2 patients (16.6%).
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The findings are limited by this being a literature review based on a small number of studies (four publications) and a total of only 22 patients.